FLT3 and acute myeloid leukemia: AML cells with FLT3-ITD mutation are characterized by constitutive auto-phosphorylation and factor-independent activation of FLT3 receptors that enhance irregular cell proliferation through various signaling pathways including PI3K/AKT, Ras/MAPK and STAT [11, 12].